Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Invested Capital (2017 - 2025)

Selectis Health's Invested Capital history spans 13 years, with the latest figure at $7.2 million for Q4 2025.

  • Quarterly results put Invested Capital at $7.2 million for Q4 2025, down 47.55% from a year ago — trailing twelve months through Dec 2025 was $7.2 million (down 47.55% YoY), and the annual figure for FY2025 was $7.2 million, down 47.55%.
  • Invested Capital for Q4 2025 was $7.2 million at Selectis Health, down from $12.9 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $22.2 million in Q4 2023 to a low of $1.4 million in Q3 2023.
  • The 5-year median for Invested Capital is $7.7 million (2024), against an average of $9.0 million.
  • The sharpest move saw Invested Capital plummeted 90.57% in 2021, then surged 583.54% in 2023.
  • Year by year, Invested Capital stood at $9.4 million in 2021, then plummeted by 65.48% to $3.2 million in 2022, then surged by 583.54% to $22.2 million in 2023, then plummeted by 38.22% to $13.7 million in 2024, then plummeted by 47.55% to $7.2 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $7.2 million, $12.9 million, and $12.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.